PTC923
PBD-001
Phase 2 small_molecule completed
Quick answer
PTC923 for BH4 Deficiency is a Phase 2 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- BH4 Deficiency
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed